Phibro Animal Health Corporation (NASDAQ:PAHC) Declares Quarterly Dividend of $0.12

Phibro Animal Health Corporation (NASDAQ:PAHC) declared a quarterly dividend on Tuesday, November 4th. Investors of record on Wednesday, November 26th will be given a dividend of 0.12 per share on Wednesday, December 17th. This represents a c) annualized dividend and a dividend yield of 1.2%. The ex-dividend date of this dividend is Wednesday, November 26th.

Phibro Animal Health has a dividend payout ratio of 23.9% indicating that its dividend is sufficiently covered by earnings. Research analysts expect Phibro Animal Health to earn $2.10 per share next year, which means the company should continue to be able to cover its $0.48 annual dividend with an expected future payout ratio of 22.9%.

Phibro Animal Health Stock Down 3.5%

Shares of NASDAQ:PAHC traded down $1.48 during trading on Wednesday, hitting $40.64. The company’s stock had a trading volume of 13,117 shares, compared to its average volume of 274,316. The stock’s 50-day moving average price is $39.31 and its two-hundred day moving average price is $30.50. Phibro Animal Health has a fifty-two week low of $16.16 and a fifty-two week high of $44.35. The company has a market capitalization of $1.65 billion, a PE ratio of 34.44, a PEG ratio of 1.24 and a beta of 0.83. The company has a debt-to-equity ratio of 2.46, a quick ratio of 1.25 and a current ratio of 2.76.

Phibro Animal Health (NASDAQ:PAHC) last issued its quarterly earnings data on Wednesday, August 27th. The company reported $0.57 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.52 by $0.05. Phibro Animal Health had a return on equity of 32.14% and a net margin of 3.73%.The business had revenue of $378.70 million during the quarter, compared to analyst estimates of $362.24 million. Phibro Animal Health has set its FY 2026 guidance at 2.520-2.700 EPS. As a group, sell-side analysts expect that Phibro Animal Health will post 1.95 EPS for the current year.

Wall Street Analyst Weigh In

A number of equities analysts recently issued reports on the company. Zacks Research raised Phibro Animal Health from a “hold” rating to a “strong-buy” rating in a report on Monday, September 29th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Phibro Animal Health in a research note on Tuesday, October 14th. Bank of America increased their price target on Phibro Animal Health from $19.00 to $27.00 and gave the company an “underperform” rating in a research note on Friday, August 29th. Finally, Morgan Stanley set a $34.00 price target on Phibro Animal Health in a research note on Thursday, August 28th. One research analyst has rated the stock with a Strong Buy rating, one has given a Buy rating, four have issued a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat, Phibro Animal Health has a consensus rating of “Hold” and a consensus target price of $28.40.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.